Data Collective Closes $725 Million For Fifth Fund

By Amit Chowdhry ● Sep 20, 2019
  • Venture firm Data Collective announced that it closed $725 million for its fifth fund called DCVC V

Venture firm Data Collective is known for creating some of the most important computing resources that are used today. And the venture firm’s early investments became the building blocks of computing giants like AWS, Microsoft Azure, Google Cloud, Illumina, and VMware. And Data Collective co-managing partners Matt Ocko and Zachary Bogue recently announced that the venture firm has closed $725 million for its fifth fund called DCVC V.

“We are grateful that our success to date enabled us to close DCVC V, a new $725 million Deep Tech fund, our eighth overall. DCVC V will continue to back early-stage Deep Tech teams as well as doubling down on key later-stage opportunities as they emerge from within our portfolio. This fund, roughly twice the size of our prior vintage of funds, is one of the largest raises to date for Deep Tech,” wrote Ocko and Bogue.

In the last decade, the companies that Data Collective funded have addressed a broader spectrum of global GDP with each successive year. Some of the key sectors that DCVC V is investing in include companies that are transforming unsustainable global manufacturing, relieving an overstressed global food supply, curing seemingly incurable diseases, defeating terrorists and criminals, and providing tools and systems to massively accelerate human innovation overall.

“We recognize that solving tough global challenges requires a deep bench of talented individuals. To support our new efforts, we continue to strengthen our team. First, we promoted Kelly Chen, a principal at DCVC with a strong track record and deep understanding of our investment thesis, to partner. Alan Cohen, formerly of Cisco, Nicira and Illumio, and Matt Michelsen, formerly an advisor to 8VC, have joined as partners, bringing with each of them multiple decades of hard-won experience. And Kate Reed joins us as VP of marketing and communications to help our companies tell their important stories,” added Ocko and Bogue.

Some of the companies that DCVC invested in include Pivot Bio, Planet, Zymergen, Atomwise, Rocket Lab, Recursion Pharmaceuticals, Embark, and Gro Intelligence.